Effect of Food on the Pharmacokinetics of LY2835219 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 23 Aug 2018
Price : $35 *
At a glance
- Drugs Abemaciclib (Primary)
- Indications Breast cancer; Cancer; Mantle-cell lymphoma; Non-small cell lung cancer
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 15 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 11 Jul 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 25 Feb 2014 Planned End Date changed from 1 May 2014 to 1 Aug 2014, as per ClinicalTrials.gov record.